Education Library

Resources for Health Care Professionals

Filter Results

Condition

Audience

Topic

Type

What is NCSI Study?

The NCSI Study is based on adopting the best practices algorithm focused on identifying shock early and unloading using Impella devices before PCI, reducing use of inotropes, and the use of invasive hemodynamic monitoring to aid in escalation and weaning.

What is the STEMI DTU™ Pilot Trial?

The STEMI DTU pilot trial demonstrated for the first time that LV unloading using the Impella CP® heart pump with a 30-minute delay before reperfusion is safe and feasible

What is A-CURE?

The clinical, preclinical, and basic research of A-CURE focuses primarily on the use of the Impella® heart pump, a transvalvular microaxial flow pump, as the means to unload the heart.

National Cardiogenic Shock Initiative: 1 Year Later

William O'Neill, MD, Cindy Grines, MD, FACC, FSCAI, and Navin K. Kapur, MD, FACC, FSCAI, FAHA, discuss NCSI data after 1 year.

How is Closure Managed with Impella® Heart Pumps?

Review the key steps of the manual compression technique.

What Size Access Sheath is Used with Impella® Heart Pumps?

Review the access sheath sized used for Impella heart pumps in this FAQ.

Complex PCI Involving Prior CABG and Comorbidities

Perwaiz Meraj, MD, presents a complex coronary intervention Protected PCI case with hemodynamic support from the Impella CP® heart pump. 

Training Video for the Axillary Insertion Kit

This Quick Skills Video depicts insertion of the Impella 5.0 with the Axillary Insertion Kit.

Heart Team Approach to Treating Cardiogenic Shock

Alexander Truesdell, MD, discusses best practices based on his team’s real-world experience treating cardiogenic shock.

Impella RP® Weaning Recommendations from Tim Larkin, MD

Dr. Tim Larkin describes his weaning protocol for the Impella RP heart pump during this physician Q&A session.

Clinical Options for Minimizing Contrast Exposure and Reducing Contrast-Induced Kidney Injury Risk

Contrast-induced acute kidney injury (AKI) caused by iodinated contrast medium is associated with high morbidity and mortality in at-risk patients.

CTO Impact on the Long-Term Prognosis of Ischemic Systolic Heart Failure

This study shows that presence of CTO in patients with coronary artery disease (CAD) with ischemic heart failure results in adverse long-term prognosis.

How Impella 2.5® Provides Hemodynamic Support During Protected PCI

Watch how Impella 2.5® provides hemodynamic support during Protected PCI.

NPS-1674

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].